Cognition is a popular reason people look into peptides, but the options split into two camps: compounds registered and used abroad (mainly in Russia) with limited Western validation, and compounds that have only preclinical animal data. Across both, rigorous, independent human trials for healthy cognitive enhancement are scarce, so the honest framing is cautious optimism at most.
Reviewed for accuracy · Last reviewed July 8, 2026The compounds below are the ones most discussed for cognition. Each links to its full profile, where the dosing, side effects, and sources live. They are ordered roughly by how much human evidence sits behind them, not by a claim that any one works.
The best-supported items here are supported mainly by non-Western use rather than independent Western trials: semax and selank are registered in Russia, and cerebrolysin is used clinically abroad, but Cochrane reviews of cerebrolysin did not find convincing benefit. Dihexa and pinealon sit further back, on preclinical rodent and in-vitro data only.
None of these is FDA-approved for cognition, and their study populations (stroke, dementia, anxiety, or animal models) differ from healthy people seeking enhancement. Several are research-only compounds, so product quality is an added uncertainty on top of the thin efficacy evidence.
This page is an independent educational reference and is not medical advice, and does not indicate any approval status for any use. Talk to a doctor before starting any compound.